Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
Zootecnia
DOI:
https://doi.org/10.5433/1679-0359.2023v44n1p343Keywords:
Antibiotics, Performance, Pneumonia, Cough.Abstract
Marbofloxacin is one of the antibiotics of choice for the treatment of pigs with clinical manifestations of respiratory disease. Some commercial products on the market contain this active ingredient, and the objective of this study was to evaluate the efficacy of 3 available marbofloxacin-based products based on the SISAAB (single injection and short-term antibiotic) concept with regard to the performance and health parameters of pigs in the nursery, growth and termination phases with clinical manifestations of respiratory disease (RD). A total of 78 animals with clinical manifestations of RD from a total of 1726 pigs were used. The animals that had RD symptoms were weighed, identified and randomly subjected to 3 treatments: T1 - Forcyl® (n = 27); T2 - Marbox® (n = 25); T3 - Resolutor® (n = 26). All treatments corresponded to a single intramuscular dose of 8 mg of marbofloxacin per kg of live weight. After treatment, clinical signs of cough and depression, water consumption, rectal temperature, performance parameters, lung lesions and the pneumonia index of the animals were evaluated. The animals that received T1 and T3 maintained a mean rectal temperature of 39.38 °C 2 days after administration. In contrast, animals in the group that received T2 had significantly higher temperatures (p = 0.068) in this period (39.53 °C). There was a greater decrease in temperature (p = 0.042) in the 24 hours after drug administration in animals that received T1 (-0.573 °C). Regarding the other performance parameters, clinical signs of cough and depression, water consumption, lung injury and the pneumonia index, no differences were observed between the marbofloxacin-based products evaluated (p > 0.05). All marbofloxacin-based products were effective in reducing the clinical signs of RD and promoting animal performance and health. However, T1 was more effective in reducing the rectal temperature of the animals.
Downloads
References
Biberstein, E. L. (1990). Our understanding of the Pasteurellaceae. Canadian Journal of Veterinary Research = Revue Canadienne de Recherche Veterinaire, 54(Suppl.), S78-82.
Christensen, G., Sorensen, V., & Mousing, J. (2006). Diseases of the respiratory system. In J. J. Zimmerman, L. A. Karriker, K. J. Schwartz, G. W. Stevenson, & A. Ramirez (Eds.), Diseases of swine (9nd ed., pp. 913-940). Ames.
Craig, W. A., & Gudmundsson, S. (1996). The postantibiotic effect. In V. Lorian (Ed.), Antibiotics in laboratory medicine (4nd ed., pp. 296-329). Baltimore The Williams & Wilkins Co.
Ding, H., Li, Y., Chen, Z., Rizwan-Ul-Haq, M., & Zeng, Z. (2010). Plasma and tissue cage fluid pharmacokinetics of marbofloxacin after intravenous, intramuscular, and oral single-dose application in pigs. Journal of Veterinary Pharmacology and Therapeutics, 33(5), 507-510. doi: 10.1111/j.1365-2885.2010.01164.x DOI: https://doi.org/10.1111/j.1365-2885.2010.01164.x
Dorey, L., Pelligand, L., & Lees, P. (2017). Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida bypharmacokinetic/pharmacodynamic modelling. BMC Veterinary Research, 13(1), 1-10. doi: 10.1186/s12917-017-1128-y DOI: https://doi.org/10.1186/s12917-017-1128-y
El Garch, F., Kroemer, S., Galland, D., Morrissey, I., & Woehrle, F. (2017). Survey of susceptibility to marbofloxacin in bacteria isolated from diseased pigs in Europe. Veterinary Record, 180(24), 34-60. doi: 10.1136/vr.103954 DOI: https://doi.org/10.1136/vr.103954
European Medicines Evaluation Agency - EMEA (1998). Committee for veterinary medicinal products - Mecillinam. Report.
Escobar, J., van Alstine, W. G., Baker, D. H., & Johnson, R. W. (2007). Behaviour of pigs with viral and bacterial pneumonia. Applied Animal Behaviour Science, 105(1-3), 42-50. doi: 10.1016/j.applanim.2006.06.005 DOI: https://doi.org/10.1016/j.applanim.2006.06.005
Garcia-Morante, B., Segalés, J., Fraile, L., Pérez de Rozas, A., Maiti, H., Coll, T., & Sibila, M. (2016). Assessment of Mycoplasma hyopneumoniae-induced pneumonia using different lung lesion scoring systems: a comparative review. Journal of Comparative Pathology, 154(2-3), 125-134. doi: 10.1016/J.JCPA.2015.11.003 DOI: https://doi.org/10.1016/j.jcpa.2015.11.003
Grandemange, E., Perrin, P. A., Cvejic, D., Haas, M., Rowan, T., & Hellmann, K. (2017). Randomised controlled field study to evaluate the efficacy and clinical safety of a single 8 mg/kg injectable dose of marbofloxacin compared with one or two doses of 7.5 mg/kg injectable enrofloxacin for the treatment of Actinobacillus pleuropneumoniae infections in growingfattening pigs in Europe. Porcine Health Management, 3(1), 1-12. doi: 10.1186/S40813-017-0057-2/FIGURES/1 DOI: https://doi.org/10.1186/s40813-017-0057-2
Haritova, A. M., Rusenova, N. V, Parvanov, P. R., Lashev, L. D., & Fink-Gremmels, J. (2006). Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys. Veterinary Research Communications, 30(7), 775-789. doi: 10.1007/s11259-006-3400-7 DOI: https://doi.org/10.1007/s11259-006-3400-7
Hart, B. L. (2009). Beyond fever: comparative perspectives on sickness behavior. Encyclopedia of Animal Behavior, 1, 205-210. doi: 10.1016/B978-0-08-045337-8.00133-9 DOI: https://doi.org/10.1016/B978-0-08-045337-8.00133-9
Hoeltig, D., Rohde, J., Brunner, B., Hellmann, K., Grandemange, E., & Waldmann, K.-H. (2018). Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs. Porcine Health Management, 4(1), 1-10. doi: 10.1186/s40813-018-0089-2
Hossain, Md. A., Park, H., Jeong, K., Jang, Y. ho, Kim, D. G., Kang, J., & Lee, K. (2017). Pharmacokinetic and pharmacodynamic evaluation of marbofloxacin in pig against korean local isolates of Actinobacillus pleuropneumoniae. BioMed Research International, 2017(1), 2469826. doi: 10.1155/2017/2469826 DOI: https://doi.org/10.1155/2017/2469826
Lees, P., & Shojaee Aliabadi, F. (2002). Rational dosing of antimicrobial drugs: animals versus humans. International Journal of Antimicrobial Agents, 19(4), 269-284. doi: 10.1016/S0924-8579(02)00025-0 DOI: https://doi.org/10.1016/S0924-8579(02)00025-0
Nedbalcova, K., Satran, P., Jaglic, Z., Ondriasova, R., & Kucerova, Z. (2006). Haemophilus parasuis and Glässer’s disease in pigs: a review. Veterinarni Medicina, 51(3), 168-179. doi: 10.17221/5537-VETMED DOI: https://doi.org/10.17221/5537-VETMED
Nedbalcova, K., Zouharova, M., & Sperling, D. (2019). Post-antibiotic effect of marbofloxacin, enrofloxacin and amoxicillin against selected respiratory pathogens of pigs. Veterinarni Medicina, 64(2), 67-77. doi: 10.17221/123/2018-VETMED DOI: https://doi.org/10.17221/123/2018-VETMED
O’Connor, A. M., Totton, S. C., & Shane, D. (2019). A systematic review and network meta-analysis of injectable antibiotic treatment options for naturally occurring swine respiratory disease. Journal of Swine Health and Production, 27(3), 133-149. doi: 10.1017/S1466252320000031 DOI: https://doi.org/10.1017/S1466252320000031
Opriessnig, T., Giménez-Lirola, L. G., & Halbur, P. G. (2011). Polymicrobial respiratory disease in pigs. Animal Health Research Reviews, 12(2), 133-148. doi: 10.1017/S1466252311000120 DOI: https://doi.org/10.1017/S1466252311000120
Rossi, L., Turin, L., Alborali, G. L., Demartini, E., Filipe, J. F. S., Riva, F., Riccaboni, P., Scanziani, E., Trevisi, P., Dall’Ara, P., Dell’Anno, M., & Baldi, A. (2021). Translational approach to induce and evaluate verocytotoxic E. coli O138 based disease in piglets. Animals, 11(8), 1-17. doi: 10.3390/ani11082415 DOI: https://doi.org/10.3390/ani11082415
Sargeant, J. (2018). Protocol for a systematic review on antibiotic for prevention in swine. Guelph.
Schneider, M., Paulin, A., Dron, F., & Woehrlé, F. (2014). Pharmacokinetics of marbofloxacin in pigs after intravenous and intramuscular administration of a single dose of 8 mg/kg: dose proportionality, influence of the age of the animals and urinary elimination. Journal of Veterinary Pharmacology and Therapeutics, 37(6), 523-530. doi: 10.1111/jvp.12125 DOI: https://doi.org/10.1111/jvp.12125
Sun, J., Xiao, X., Huang, R.-J., Yang, T., Chen, Y., Fang, X., Huang, T., Zhou, Y.-F., & Liu, Y.-H. (2015). In vitro dynamic pharmacokinetic/pharamcodynamic (PK/PD) study and COPD of marbofloxacin against Haemophilus parasuis. BMC Veterinary Research, 11(1), 2-8. doi: 10.1186/s12917-015-0604-5 DOI: https://doi.org/10.1186/s12917-015-0604-5
Thomas, E., Grandemange, E., Pommier, P., Wessel-Robert, S., & Davot, J. L. (2000). Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs. The Veterinary Quarterly, 22(3), 131-135. doi: 10.1080/01652176.2000.9695041 DOI: https://doi.org/10.1080/01652176.2000.9695041
Vallé, M., Schneider, M., Galland, D., Giboin, H., & Woehrlé, F. (2012). Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics, 35(6), 519-528. doi: 10.1111/J.1365-2885.2011.01350.X DOI: https://doi.org/10.1111/j.1365-2885.2011.01350.x
Vilalta, C., Giboin, H., Schneider, M., Garch, F. el, & Fraile, L. (2014). Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations. Journal of Veterinary Pharmacology and Therapeutics, 37(6), 542-549. doi: 10.1111/JVP.12134 DOI: https://doi.org/10.1111/jvp.12134
Vilalta, C., Schneider, M., López-Jimenez, R., Caballero, J. M., Gottschalk, M., & Fraile, L. (2011). Marbofloxacin reaches high concentration in pig tonsils in a dose-dependent fashion. Journal of Veterinary Pharmacology and Therapeutics, 34(1), 95-97. doi: 10.1111/J.1365-2885.2010.01206.X DOI: https://doi.org/10.1111/j.1365-2885.2010.01206.x
Yang, F., Liu, Y., Li, Z., Wang, Y., Liu, B., Zhao, Z., Zhou, B., & Wang, G. (2017). Tissue distribution of marbofloxacin in pigs after a single intramuscular injection. Journal of Veterinary Science, 18(2), 169-173. doi: 10.4142/jvs.2017.18.2.169 DOI: https://doi.org/10.4142/jvs.2017.18.2.169
Zou, M., & Zeng, Z. (2012). Efficacy of marbofloxacin against experimentally induced Actinobacillus pleuropneumoniae in swine. Southwest China Journal of Agricultural Sciences, 25(6), 2333-2337. doi: 10.1186/s40813-018-0089-2 DOI: https://doi.org/10.1186/s40813-018-0089-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Semina: Ciências Agrárias
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Semina: Ciências Agrárias adopts the CC-BY-NC license for its publications, the copyright being held by the author, in cases of republication we recommend that authors indicate first publication in this journal.
This license allows you to copy and redistribute the material in any medium or format, remix, transform and develop the material, as long as it is not for commercial purposes. And due credit must be given to the creator.
The opinions expressed by the authors of the articles are their sole responsibility.
The magazine reserves the right to make normative, orthographic and grammatical changes to the originals in order to maintain the cultured standard of the language and the credibility of the vehicle. However, it will respect the writing style of the authors. Changes, corrections or suggestions of a conceptual nature will be sent to the authors when necessary.
